Forma Therapeutics Reviews 2020 Highlights and Outlines Key 2021 Milestones
Forma Therapeutics Reviews 2020 Highlights and Outlines Key 2021 Milestones Forma Therapeutics Reviews 2020 Highlights and Outlines Key 2021 Milestones Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today provided a review of corporate highlights from 2020 and outlined anticipated key clinical program milestones for 2021. While 2020 was marked by tremendous challenges due to the COVID-19 pandemic...
United States Megan Mcgrath Frank Lee American Society Of Clinical Oncology European Hematology Association American Society Of Hematology
Source: globalbankingandfinance.com